The modest response of the ERα+ breast and ovarian cancer cell lines to estrogen supplementation in vitro (especially under 3D conditions) prompted us to test whether estrogen can help establish HGSC xenografts in the highly immunocompromised NSG mice. The gene discussed is ESR1; the disease is ovarian carcinoma.